Point Of Care Diagnostics Market Worth $30.9 Billion by 2024.- Exclusive Report by Meticulous Research®

A report into the projected growth of the current point of care diagnostics market by Meticulous Research® has produced some incredible forecasts for the industry. By 2024, it's expected to have grown at a CAGR of 8%, reaching $30.9 billion.
Future Outlook: Point of Care (POC) Diagnostics Market to Offer Significant Growth Opportunities
In a report published today, Meticulous Research® has stated that the size of the global point of care diagnostics market will reach an impressive $30.9 billion by 2024.

The researchers predict that significant growth will be driven by variety of factors including growing incidence of target diseases such as cancer, diabetes, cardiovascular diseases, and infectious diseases; the need for rapid results in certain medical situations; increasing usage of home-based tests/self-testing; rising number of CLIA-waived product approvals; and increasing funding/investment for the development of POC products.

Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4871

The report states that lateral flow assays (immunochromatography tests/lateral flow immunoassays) platform accounts for the largest share of the total point of care diagnostics market. However, point of care molecular diagnostics tests are expected to grow at a fastest CAGR of 13.3% from 2018 to 2024. Meticulous Research® anticipated as to why this area is emerging as the largest use of the platform: "The shift from the traditional microbiology-based testing to molecular testing stems from the rising antibiotic resistance crisis, and faster turnaround time of POC molecular assay tests."

Over-the-Counter (OTC) testing is cited as the major trend driving the growth of point of care diagnostics market. OTC testing kits are expected to generate relatively higher revenue than prescription tests over the forecast period owing to the associated ease of usage, growing home care and self-testing, and higher availability and greater adoption rate.

Scope of the Report:
Point Of Care Diagnostics Market by Product:
• Blood Glucose Monitoring Testing Products
o Strips
o Meters
o Lancets & Lancing Devices
• Cardiac-Metabolism Monitoring Testing Products
o Cardiac Marker
o Blood Gas/Electrolytes Testing
o HbA1c Testing
• Infectious Disease Testing Products
o Influenza Testing
o HIV Testing
o Hepatitis C Testing
o Sexually Transmitted Disease (STD) Testing
o Healthcare-Associated Infection (HAI) Testing
o Respiratory Infection Testing
o Tropical Disease Testing
o Other Infectious Disease Testing
• Coagulation Monitoring Products
o Prothrombin Time (PT/INR) Testing
o Activated Clotting Time (ACT/aPTT) Testing
• Pregnancy and Fertility Testing Products
o Pregnancy Testing
o Fertility Testing
• Tumor/Cancer Markers Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drugs of Abuse Testing Products
• Fecal Occult Testing Products
• Other POC Testing Products
Point Of Care Diagnostics Market by Platform:
• Lateral Flow Assays (Immunochromatography Tests/Lateral Flow Immunoassays)
• Dipsticks
• Microfluidics
• Molecular Diagnostics
Point Of Care Diagnostics Market by Mode:
• Prescription-based Testing
• Over-the-counter (OTC) Testing
Point Of Care Diagnostics Market by End User:
• Home Care/Self-testing
• Physician Offices & Outpatient/Ambulatory Care Settings
• Hospitals
• Research Laboratories
Point Of Care Diagnostics Market by Geography:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
• Latin America
• Middle East & Africa

Speak with Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4871

On the basis of product type, blood glucose monitoring testing currently dominates the global POC diagnostics market; however, infectious diseases testing kits segment is expected to register growth during the forecast period. Influenza causes 12,000- 50,000 deaths annually in the U.S. Rapid testing for influenza A and B allows for accurate and timely treatment, as patients only have a 48-hour window to receive critical antiviral therapy. Thus, growing prevalence of infectious diseases and need for rapid testing and treatment provide robust opportunities for POC testing companies like BD, Quidel, Roche, and Alere (Abbott). Meticulous Research® help companies operating in POC diagnostics market to identify key growth segments to invest in.

Finally, the report states that North America is currently the home of most of the point of care diagnostics companies. However, Asia-Pacific is named as the area expected to grow most by 2024. Major reasons cited for this rising demand include accelerated growth of the economies; relatively lower availability of sophisticated central laboratory testing services; a larger population base in need for clinical testing; increasing incidence of infectious and non-communicable diseases in aging population; and improving availability and awareness of POC tests.

The key players operating in the global point of care diagnostics market are Abbott Laboratories, AccuBioTech Co., Ltd., Becton Dickinson and Company, Chembio Diagnostic Systems, Inc., Danaher Corporation, EKF Diagnostics Holdings plc, WerfenLife, S.A., Johnson and Johnson Service, Inc., Nova Biomedical, F. Hoffmann-La Roche Ltd, Sekisui Diagnostics LLC, Quidel Corporation, Siemens AG, and Trinity Biotech, among others.

Browse in-depth Report on:https://www.meticulousresearch.com/product/point-of-care-diagnostics-poc-market/

About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.